Wärme J, Sundqvist MO, Hjort M, Agewall S, Collste O, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Spaak J, Sörensson P, Y-Hassan S, Svensson P, Lindahl B, Hofmann R, Tornvall P(2023) Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease Int J Mol Sci, 24(18) DOI 10.3390/ijms241814143, PubMed 37762446
Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D(2023) Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy Am J Ther, 30(5), e411-e415 DOI 10.1097/MJT.0000000000001622, PubMed 37713684
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SFet al.(2023) Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia Cardiovasc Diabetol, 22(1), 233 DOI 10.1186/s12933-023-01963-9, PubMed 37653496